|Name||PRICE||MARKET CAPITALIZATION||PRICE TO EARNINGS RATIO||DIVIDEND YIELD||SYMBOL||EXCHANGE||PRICE PERCENT DIFFERENCE||YEAR TO DATE PRICE PERCENT DIFFERENCE||5 YEAR CHART||1 YEAR CHART|
Guardant Health Inc is a precision oncology company. It is focused on helping conquer cancer globally through the use of proprietary blood tests, vast data sets, and advanced analytics. The company only reportable segment: delivering precision oncology testing and development services. Geographically, the company generates a majority of its revenue from the United States. its solutions include treatment selection, recurrence, and early detection.
GH $79.01 -6.06 (-7.12%)
Sector Health Care
Industry Medical Diagnostics & Research
Market Cap 6.79 Billion
EPS -2.08 P/E Ratio 0.00
Previous Earnings --
Latest Earnings --
Dividend Pay Date --
Dividend History --
Investing Quotes #Legendary
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.
Some links on this website are advertisements and/or affiliate links and Symbol Surfing receives compensation.